The Board of Directors have recommended a final dividend of ₹35 per equity share, i.e., 350% for the financial year FY25
The two stocks that have touched their 52-week highs are ICICI bank and HDFC Life
The company also said this issue relates to the entire industry where the GST department has sent notices to various other gaming companies prior to this.
The hospital chain’s EBITDA for the March 2025 quarter jumped 22.7 YoY% to ₹57.2 crore against ₹46.6 crore in Q4 FY24
Revenue from operations in the quarter was at ₹534 crore, a 13% increase from ₹471 crore in Q4 FY24
An EBITDA of ₹498 crore at Q4 FY25 shrank by 6.4% over ₹532.2 crore in the corresponding quarter last year.
Revenue from operations was down by 20.3% y-o-y to ₹1,360.9 crore in Q4 FY25 from ₹1,708.2 crore in Q4 FY24
The company has a strong foothold in the Indian pharma market as well as in the international market where it sells its products in more than 55 countries
Revenue increased 11% YoY to ₹265.30 crore from ₹240 crore in Q4 FY24, suggesting healthy sales traction.
Annual income at the company also grew by a big margin of ₹31,724 crore in FY25 from ₹29,002 crore in FY24, up 9.4% on yearly basis
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.